ICICI Bank’s record is one of steady operating performance and rising shareholder returns, set against a backdrop of recurring regulatory friction and a balance sheet that has absorbed large structural shifts without touching the profit-and-loss account. Three things stand out: a ₹1,283 crore RBI-directed provision that signals a live supervisory concern, a ₹13,100 crore discretionary provision stock that has sat unused while regulatory transitions routed gains around earnings, and a pattern of regulatory penalties and warnings sustained across multiple years.
Key findings
- RBI directed a ₹1,283 crore provision for agricultural loans that did not meet PSL classification rules
Major- The Reserve Bank of India directed ICICI Bank in FY2026 to make a standard asset provision of ₹1,283 crore on a portfolio of agricultural priority-sector credit facilities found not fully compliant with regulatory classification requirements, though asset classification and borrower terms were left unchanged. Management stated in the Q4 FY2026 transcript dated March 2026 that an update on the portfolio is expected “a quarter-or-so from now”. - A large stock of discretionary provisions and revaluation reserves has cushioned profit, while regulatory transitions bypassed earnings
Major- The Bank held a contingency provision of ₹13,100 crore at March 31, 2026, unchanged from the two prior years, and made no addition during FY2025-FY2026. Management confirmed in Q4 FY2026 that the Bank “continues to hold contingency provisions of ₹13,100 crore” and “have not utilised” them, while total provisions other than specific NPA provisions stood at ₹22,710 crore, or 1.5% of loans. Separately, the Bank recognised a net transition gain of ₹2,058.31 crore (net of tax) in the AFS reserve and ₹1,156.1 crore (net of tax) in the General reserve upon adopting the RBI Master Direction on investment classification effective April 1, 2024, bypassing the profit and loss account. Premises carried at a revalued amount of ₹6,175.85 crore against a historical cost less accumulated depreciation of ₹2,291.31 crore created a revaluation reserve of ₹3,884.54 crore that is not available for dividends. - Regulatory penalties and warnings have arrived in a sustained pattern across multiple years
Major- RBI imposed monetary penalties of ₹12.19 crore in October 2023 for deficiencies observed during statutory inspections, ₹1.00 crore in May 2024 for contravention of its Master Circular on loans and advances, ₹0.98 crore in April 2025 for non-compliance with its Cyber Security Framework and KYC directions, and ₹0.75 crore in August 2025 for non-compliance with directions on property valuation and current accounts. Earlier penalties included ₹3.0 crore in May 2021 for shifting investments from HTM to AFS without explicit permission and ₹0.3 crore in December 2021 for non-compliance on penal charges. SEBI issued an administrative warning on March 20, 2025 for procedural irregularities in custodian activities and another on February 28, 2025 for Designated Depository Participant activities, an administrative warning in June 2024 regarding an outreach programme for the ICICI Securities delisting, and a Show Cause Notice in May 2018; SEBI directed the Bank on June 4, 2025, pursuant to a SAT order dated May 2, 2025 in an appeal filed by the former Managing Director & CEO, and the Bank has filed a review application before SAT. - Contingent tax demands have climbed to ₹9,400 crore with no provision, while the ICICI Securities delisting faces shareholder appeals
Minor- The Bank’s contingent tax liability assessed by tax authorities rose from ₹7,047 crore at March 31, 2021 to ₹9,400 crore at September 30, 2025, with no provision made as each demand is under appeal. Key disputed items as of November 30, 2023 included ₹2,830 crore on allocation of interest expenses to tax-exempt income and ₹1,500 crore on disallowance of mark-to-market losses on derivatives. The Bank also disclosed that ₹7,520 crore of disputed tax demands are classified as remote and not shown as contingent liability as of December 23, 2025. The Scheme of Arrangement for delisting ICICI Securities, approved by shareholders on March 27, 2024, is pending final NCLT approval and faces appeals before NCLAT filed by two shareholders in September and November 2024. - Shareholder approval is routinely sought for material related-party transactions with subsidiaries and associates
Minor- For FY2028, the Bank proposes material related-party transactions with ICICI Prudential Life Insurance up to ₹39,790 crore, with ICICI Lombard General Insurance up to ₹17,770 crore, and with India Infradebt Limited up to ₹18,100 crore, or 641.52% of that associate’s standalone FY2026 turnover. Actual transaction values in FY2026 were ₹2,544 crore with ICICI Life, ₹2,665 crore with ICICI General, and ₹1,821 crore with India Infradebt, all well below the proposed FY2028 limits. - Executive remuneration and stock-option grants have risen year-on-year with near-unanimous shareholder approval, while a former MD & CEO’s variable pay remains under a claw-back suit
Minor- Sandeep Bakhshi’s monthly basic salary rose from ₹2,500,050 in FY2022 to ₹2,887,300 in FY2024-FY2026 and is proposed at ₹2,945,050 from April 1, 2026, while his annual performance bonus increased from 2.25 crore in FY2021 to 3.52 crore in FY2026. The weighted average fair value of stock options granted rose from ₹125.44 in FY2021 to ₹424.14 in FY2026. The Bank has filed a recovery suit against the former MD & CEO for claw-back of ₹7.41 crore in variable pay, disclosed consistently from FY2021 through FY2024. - Operating cash flow swung from deeply negative to strongly positive, while dividends per share rose sixfold
Clean- Consolidated CFO moved from ₹-3,771 crore in FY23 to ₹157,284 crore in FY24, ₹122,805 crore in FY25, and ₹67,325 crore in FY26, while consolidated PAT grew from ₹26,538 crore in FY22 to ₹57,673 crore in FY26. The CFO/PAT ratio was 3.41x in FY24, 2.25x in FY25, and 1.17x in FY26. Dividend per share recommended by the Board rose from ₹2 in FY21 to ₹12 in FY26.
What to watch
- Shareholder vote on FY2028 material RPT resolutions. Items 13-18 at the 32nd AGM, per the notice dated July 18, 2026.
- Director appointments and remuneration at the 32nd AGM. Vote on appointment of Ashwani Bhatia and Mrugank Paranjape as Independent Directors, re-appointment of Vibha Paul Rishi, revised remuneration for all four Executive Directors, and re-appointment of Sandeep Bakhshi as MD & CEO and Ajay Kumar Gupta as Executive Director, per the notice dated July 18, 2026.
- RBI approval for Ajay Kumar Gupta’s re-appointment. Approval awaited for the term November 27, 2026 to November 26, 2028.
- Update on the ₹1,283 crore standard asset provision portfolio. Expected “a quarter-or-so from now” from the Q4 FY2026 transcript dated March 2026.
- Outcome of the SAT review application against the SEBI order dated June 4, 2025. As reported in the FY2025-26 Annual Report.
- Outcome of NCLAT appeals against the ICICI Securities delisting scheme. Filed by shareholders in September and November 2024.
- Resolution of the ₹216.27 crore GST Show Cause Notice. Received on September 29, 2025 from Mumbai East Commissionerate.
- Outcome of appeals against ₹9,400 crore contingent tax demands. As at September 30, 2025.
Bottom line: This is a disclosed and audited record with genuine operating momentum, rising dividends, and a cash-flow cycle that has normalised after an exceptional surge. The weight sits in the regulatory relationship: a directed provision, a multi-year pattern of penalties, and a large discretionary provision stock and revaluation reserves sit on the balance sheet. Watch the RBI’s next word on the ₹1,283 crore portfolio, the shareholder vote on the FY2028 RPT limits, and whether the goodwill balance faces its first impairment test.